Exicure, Inc. (XCUR) Financials
XCUR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 11.4 million | 10.4 million |
| March 31, 2026 | 12.8 million | 10.7 million |
| Dec. 31, 2025 | 14.0 million | 10.1 million |
| Sept. 30, 2025 | 15.3 million | 8.3 million |
XCUR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -887000 | ? |
| March 31, 2026 | -1.1 million | ? |
| Dec. 31, 2025 | -934000 | 2000 |
| Sept. 30, 2025 | -3.4 million | ? |
XCUR Net Income
No data available :(
XCUR Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 1.7 million | - | - |
| March 31, 2026 | 2.6 million | - | 22000 |
| Dec. 31, 2025 | 3.7 million | - | 176000 |
| Sept. 30, 2025 | 4.4 million | - | 26000 |
XCUR Shares Outstanding
XCUR Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 174000 | 889000 | - |
| March 31, 2026 | - | 312000 | 1.2 million | - |
| Dec. 31, 2025 | 213000 | 655000 | 1.6 million | - |
| Sept. 30, 2025 | 106000 | 888000 | 1.5 million | - |
XCUR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 106000 |
| Dec. 31, 2025 | - | 157000 |
| Sept. 30, 2025 | - | - |
XCUR
Price: $1.43
52 week price:
Earnings Per Share: -1.57 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 9300
Market Capitalization: 8.0 million